Conversely, an administration of antiserum against NGF attenuates or prevents the development of hypertension and vascular hypertrophy concomitantly with reductions in sympathetic innervation and sympathetic neural activity in SHRs [13–16]. This evidence concerns the gene NGF and hypertensive disorder.